Roger Kirby – författare

Radical prostatectomy involves the surgical removal of the entire prostate gland and the seminal vesicles. Recently the open operation has been challenged by laparoscopic and robotic techniques. However, making the transition to this new technology is not an easy option. Avoiding surgical complications such as incontinence and ensuring continued er

Erectile dysfunction (ED) affects 20-30 million American men, most of whom are over 50 years of age. In a UK-based study, 32% of British men had difficulty obtaining an erection, 20% with maintaining an erection. In recent years the physiology and pathophysiology of ED  have changed our understanding of what ED is from a purely psychological-b

Erectile dysfunction (ED) affects 20-30 million American men, most of whom are over 50 years of age. In a UK-based study, 32% of British men had difficulty obtaining an erection, 20% with maintaining an erection. In recent years the physiology and pathophysiology of ED  have changed our understanding of what ED is from a purely psychological-b

Radical prostatectomy involves the surgical removal of the entire prostate gland and the seminal vesicles. Recently the open operation has been challenged by laparoscopic and robotic techniques. However, making the transition to this new technology is not an easy option. Avoiding surgical complications such as incontinence and ensuring continued er

Technology seems to be an integral part of modern living. Urologists have over the years embraced new technological advances for patient beneft. On some occasions, however, the initial enthusiasm in something new has failed to endure rigorous scientifc scrutiny. Thus, while being technological leaders, we urologists know better than most other surgical speci- ties that what is new is not necessarily good. This textbook is aimed at urologists and surgeons at all levels and has contributions from international experts. The topics vary from robotics to lasers to single port laparoscopy. The comprehensive chapters should be of equal interest to uro-oncologists and those involved in treating benign urological diseases. While the contents are meant to bring the reader up to date with technological advances, the authors have attempted to balance their enthusiasm with basic science, translational research, and clinical outcomes. It will be obvious that some of the s- jects mentioned here, such as nanotechnology, are still evolving, and it will be a while before they undergo clinical trials that establish their position in clinical medicine. We hope you enjoy reading this book as much as we have enjoyed creating it. London, UK Prof. Prokar Dasgupta Dublin, Ireland Prof. John Fitzpatrick London, UK Prof. Roger Kirby CA, USA Prof. Inderbir S. Gill vii Acknowledgements The editors thank all authors for their time and valuable contributions. We are also grateful to our developmental editors Joni Fraser and Barbara Lopez-Lucio.

Radical prostatectomy involves the surgical removal of the entire prostate gland and the seminal vesicles. Recently the open operation has been challenged by laparoscopic and robotic techniques. However, making the transition to this new technology is not an easy option. Avoiding surgical complications such as incontinence and ensuring continued erectile function following the procedure requires good surgical technique by whatever means. The editors and their distinguished team of contributors from around the world offer the reader their guidance based on personal experience and best surgical practice. Radical Prostatectomy is required reading for all those performing radical prostatectomy by open, laparoscopic or robotic techniques.

Erectile dysfunction (ED) affects 20-30 million American men, most of whom are over 50 years of age. In a UK-based study, 32% of British men had difficulty obtaining an erection, 20% with maintaining an erection. In recent years the physiology and pathophysiology of ED  have changed our understanding of what ED is from a purely psychological-based disorder to a multifactorial one, with neurological, endocrinological, psychological factors and the role of the vascular system. Recently identified risk factors include diabetes, cardiovascular disease, spinal cord injury, smoking, depression, atherosclerosis, hypertension, pelvic surgery and trauma, pharmacological medications, arthritis, peripheral vascular disease, substance abuse, endocrine abnormalities and peptic ulcer disease. Many ED patients have a combination of these risk factors, thus exacerbating ED further. The treatment of ED was revolutionized in 1998 with the introduction of sildenafil. Beside these oral treatments, newer injectable agents are being investigated as are topical preparations. However, not all patients are tolerant of oral agents, many patients still require penile reconstruction with penile implants, an option with low complications and morbidity. There are options for all patients and this excellent, updated text, edited by some of the world's leading authorities - Culley Carson, Roger Kirby and Irwin Goldstein - discusses them all.

Technology seems to be an integral part of modern living. Urologists have over the years embraced new technological advances for patient beneft. On some occasions, however, the initial enthusiasm in something new has failed to endure rigorous scientifc scrutiny. Thus, while being technological leaders, we urologists know better than most other surgical speci- ties that what is new is not necessarily good. This textbook is aimed at urologists and surgeons at all levels and has contributions from international experts. The topics vary from robotics to lasers to single port laparoscopy. The comprehensive chapters should be of equal interest to uro-oncologists and those involved in treating benign urological diseases. While the contents are meant to bring the reader up to date with technological advances, the authors have attempted to balance their enthusiasm with basic science, translational research, and clinical outcomes. It will be obvious that some of the s- jects mentioned here, such as nanotechnology, are still evolving, and it will be a while before they undergo clinical trials that establish their position in clinical medicine. We hope you enjoy reading this book as much as we have enjoyed creating it. London, UK Prof. Prokar Dasgupta Dublin, Ireland Prof. John Fitzpatrick London, UK Prof. Roger Kirby CA, USA Prof. Inderbir S. Gill vii Acknowledgements The editors thank all authors for their time and valuable contributions. We are also grateful to our developmental editors Joni Fraser and Barbara Lopez-Lucio.